Global Fast-acting Human Insulin Supply, Demand and Key Producers, 2023-2029
The global Fast-acting Human Insulin market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Fast-acting Human Insulin production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Fast-acting Human Insulin, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Fast-acting Human Insulin that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Fast-acting Human Insulin total production and demand, 2018-2029, (K Units)
Global Fast-acting Human Insulin total production value, 2018-2029, (USD Million)
Global Fast-acting Human Insulin production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Fast-acting Human Insulin consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Fast-acting Human Insulin domestic production, consumption, key domestic manufacturers and share
Global Fast-acting Human Insulin production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Fast-acting Human Insulin production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Fast-acting Human Insulin production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Fast-acting Human Insulin market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Geropharm, Wockhardt, Novo Nordisk, Eli Lilly and Company, Mannkind, Biocon, Julphar and ADOCIA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Fast-acting Human Insulin market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Fast-acting Human Insulin Market, By Region:
1. How big is the global Fast-acting Human Insulin market?
2. What is the demand of the global Fast-acting Human Insulin market?
3. What is the year over year growth of the global Fast-acting Human Insulin market?
4. What is the production and production value of the global Fast-acting Human Insulin market?
5. Who are the key producers in the global Fast-acting Human Insulin market?
This report studies the global Fast-acting Human Insulin production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Fast-acting Human Insulin, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Fast-acting Human Insulin that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Fast-acting Human Insulin total production and demand, 2018-2029, (K Units)
Global Fast-acting Human Insulin total production value, 2018-2029, (USD Million)
Global Fast-acting Human Insulin production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Fast-acting Human Insulin consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Fast-acting Human Insulin domestic production, consumption, key domestic manufacturers and share
Global Fast-acting Human Insulin production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Fast-acting Human Insulin production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Fast-acting Human Insulin production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Fast-acting Human Insulin market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Geropharm, Wockhardt, Novo Nordisk, Eli Lilly and Company, Mannkind, Biocon, Julphar and ADOCIA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Fast-acting Human Insulin market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Fast-acting Human Insulin Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Lispro Insulin
- Aspart Insulin
- Glulisine Insulin
- Type 1 Diabetes
- Type 2 Diabetes
- Sanofi
- Geropharm
- Wockhardt
- Novo Nordisk
- Eli Lilly and Company
- Mannkind
- Biocon
- Julphar
- ADOCIA
- Tonghua Dongbao Pharmaceutical
- Gan & Lee Pharmaceuticals
- Zhejiang Hisun Pharmaceutical
- Wuhan Biology Chemical Pharmacy
1. How big is the global Fast-acting Human Insulin market?
2. What is the demand of the global Fast-acting Human Insulin market?
3. What is the year over year growth of the global Fast-acting Human Insulin market?
4. What is the production and production value of the global Fast-acting Human Insulin market?
5. Who are the key producers in the global Fast-acting Human Insulin market?
1 SUPPLY SUMMARY
1.1 Fast-acting Human Insulin Introduction
1.2 World Fast-acting Human Insulin Supply & Forecast
1.2.1 World Fast-acting Human Insulin Production Value (2018 & 2022 & 2029)
1.2.2 World Fast-acting Human Insulin Production (2018-2029)
1.2.3 World Fast-acting Human Insulin Pricing Trends (2018-2029)
1.3 World Fast-acting Human Insulin Production by Region (Based on Production Site)
1.3.1 World Fast-acting Human Insulin Production Value by Region (2018-2029)
1.3.2 World Fast-acting Human Insulin Production by Region (2018-2029)
1.3.3 World Fast-acting Human Insulin Average Price by Region (2018-2029)
1.3.4 North America Fast-acting Human Insulin Production (2018-2029)
1.3.5 Europe Fast-acting Human Insulin Production (2018-2029)
1.3.6 China Fast-acting Human Insulin Production (2018-2029)
1.3.7 Japan Fast-acting Human Insulin Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Fast-acting Human Insulin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Fast-acting Human Insulin Major Market Trends
2 DEMAND SUMMARY
2.1 World Fast-acting Human Insulin Demand (2018-2029)
2.2 World Fast-acting Human Insulin Consumption by Region
2.2.1 World Fast-acting Human Insulin Consumption by Region (2018-2023)
2.2.2 World Fast-acting Human Insulin Consumption Forecast by Region (2024-2029)
2.3 United States Fast-acting Human Insulin Consumption (2018-2029)
2.4 China Fast-acting Human Insulin Consumption (2018-2029)
2.5 Europe Fast-acting Human Insulin Consumption (2018-2029)
2.6 Japan Fast-acting Human Insulin Consumption (2018-2029)
2.7 South Korea Fast-acting Human Insulin Consumption (2018-2029)
2.8 ASEAN Fast-acting Human Insulin Consumption (2018-2029)
2.9 India Fast-acting Human Insulin Consumption (2018-2029)
3 WORLD FAST-ACTING HUMAN INSULIN MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Fast-acting Human Insulin Production Value by Manufacturer (2018-2023)
3.2 World Fast-acting Human Insulin Production by Manufacturer (2018-2023)
3.3 World Fast-acting Human Insulin Average Price by Manufacturer (2018-2023)
3.4 Fast-acting Human Insulin Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Fast-acting Human Insulin Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Fast-acting Human Insulin in 2022
3.5.3 Global Concentration Ratios (CR8) for Fast-acting Human Insulin in 2022
3.6 Fast-acting Human Insulin Market: Overall Company Footprint Analysis
3.6.1 Fast-acting Human Insulin Market: Region Footprint
3.6.2 Fast-acting Human Insulin Market: Company Product Type Footprint
3.6.3 Fast-acting Human Insulin Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Fast-acting Human Insulin Production Value Comparison
4.1.1 United States VS China: Fast-acting Human Insulin Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Fast-acting Human Insulin Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Fast-acting Human Insulin Production Comparison
4.2.1 United States VS China: Fast-acting Human Insulin Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Fast-acting Human Insulin Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Fast-acting Human Insulin Consumption Comparison
4.3.1 United States VS China: Fast-acting Human Insulin Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Fast-acting Human Insulin Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Fast-acting Human Insulin Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Fast-acting Human Insulin Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Fast-acting Human Insulin Production Value (2018-2023)
4.4.3 United States Based Manufacturers Fast-acting Human Insulin Production (2018-2023)
4.5 China Based Fast-acting Human Insulin Manufacturers and Market Share
4.5.1 China Based Fast-acting Human Insulin Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Fast-acting Human Insulin Production Value (2018-2023)
4.5.3 China Based Manufacturers Fast-acting Human Insulin Production (2018-2023)
4.6 Rest of World Based Fast-acting Human Insulin Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Fast-acting Human Insulin Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Fast-acting Human Insulin Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Fast-acting Human Insulin Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Fast-acting Human Insulin Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Lispro Insulin
5.2.2 Aspart Insulin
5.2.3 Glulisine Insulin
5.3 Market Segment by Type
5.3.1 World Fast-acting Human Insulin Production by Type (2018-2029)
5.3.2 World Fast-acting Human Insulin Production Value by Type (2018-2029)
5.3.3 World Fast-acting Human Insulin Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Fast-acting Human Insulin Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Type 1 Diabetes
6.2.2 Type 2 Diabetes
6.3 Market Segment by Application
6.3.1 World Fast-acting Human Insulin Production by Application (2018-2029)
6.3.2 World Fast-acting Human Insulin Production Value by Application (2018-2029)
6.3.3 World Fast-acting Human Insulin Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Fast-acting Human Insulin Product and Services
7.1.4 Sanofi Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
7.2 Geropharm
7.2.1 Geropharm Details
7.2.2 Geropharm Major Business
7.2.3 Geropharm Fast-acting Human Insulin Product and Services
7.2.4 Geropharm Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Geropharm Recent Developments/Updates
7.2.6 Geropharm Competitive Strengths & Weaknesses
7.3 Wockhardt
7.3.1 Wockhardt Details
7.3.2 Wockhardt Major Business
7.3.3 Wockhardt Fast-acting Human Insulin Product and Services
7.3.4 Wockhardt Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Wockhardt Recent Developments/Updates
7.3.6 Wockhardt Competitive Strengths & Weaknesses
7.4 Novo Nordisk
7.4.1 Novo Nordisk Details
7.4.2 Novo Nordisk Major Business
7.4.3 Novo Nordisk Fast-acting Human Insulin Product and Services
7.4.4 Novo Nordisk Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Novo Nordisk Recent Developments/Updates
7.4.6 Novo Nordisk Competitive Strengths & Weaknesses
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Details
7.5.2 Eli Lilly and Company Major Business
7.5.3 Eli Lilly and Company Fast-acting Human Insulin Product and Services
7.5.4 Eli Lilly and Company Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Eli Lilly and Company Recent Developments/Updates
7.5.6 Eli Lilly and Company Competitive Strengths & Weaknesses
7.6 Mannkind
7.6.1 Mannkind Details
7.6.2 Mannkind Major Business
7.6.3 Mannkind Fast-acting Human Insulin Product and Services
7.6.4 Mannkind Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Mannkind Recent Developments/Updates
7.6.6 Mannkind Competitive Strengths & Weaknesses
7.7 Biocon
7.7.1 Biocon Details
7.7.2 Biocon Major Business
7.7.3 Biocon Fast-acting Human Insulin Product and Services
7.7.4 Biocon Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Biocon Recent Developments/Updates
7.7.6 Biocon Competitive Strengths & Weaknesses
7.8 Julphar
7.8.1 Julphar Details
7.8.2 Julphar Major Business
7.8.3 Julphar Fast-acting Human Insulin Product and Services
7.8.4 Julphar Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Julphar Recent Developments/Updates
7.8.6 Julphar Competitive Strengths & Weaknesses
7.9 ADOCIA
7.9.1 ADOCIA Details
7.9.2 ADOCIA Major Business
7.9.3 ADOCIA Fast-acting Human Insulin Product and Services
7.9.4 ADOCIA Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 ADOCIA Recent Developments/Updates
7.9.6 ADOCIA Competitive Strengths & Weaknesses
7.10 Tonghua Dongbao Pharmaceutical
7.10.1 Tonghua Dongbao Pharmaceutical Details
7.10.2 Tonghua Dongbao Pharmaceutical Major Business
7.10.3 Tonghua Dongbao Pharmaceutical Fast-acting Human Insulin Product and Services
7.10.4 Tonghua Dongbao Pharmaceutical Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
7.10.6 Tonghua Dongbao Pharmaceutical Competitive Strengths & Weaknesses
7.11 Gan & Lee Pharmaceuticals
7.11.1 Gan & Lee Pharmaceuticals Details
7.11.2 Gan & Lee Pharmaceuticals Major Business
7.11.3 Gan & Lee Pharmaceuticals Fast-acting Human Insulin Product and Services
7.11.4 Gan & Lee Pharmaceuticals Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Gan & Lee Pharmaceuticals Recent Developments/Updates
7.11.6 Gan & Lee Pharmaceuticals Competitive Strengths & Weaknesses
7.12 Zhejiang Hisun Pharmaceutical
7.12.1 Zhejiang Hisun Pharmaceutical Details
7.12.2 Zhejiang Hisun Pharmaceutical Major Business
7.12.3 Zhejiang Hisun Pharmaceutical Fast-acting Human Insulin Product and Services
7.12.4 Zhejiang Hisun Pharmaceutical Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
7.12.6 Zhejiang Hisun Pharmaceutical Competitive Strengths & Weaknesses
7.13 Wuhan Biology Chemical Pharmacy
7.13.1 Wuhan Biology Chemical Pharmacy Details
7.13.2 Wuhan Biology Chemical Pharmacy Major Business
7.13.3 Wuhan Biology Chemical Pharmacy Fast-acting Human Insulin Product and Services
7.13.4 Wuhan Biology Chemical Pharmacy Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Wuhan Biology Chemical Pharmacy Recent Developments/Updates
7.13.6 Wuhan Biology Chemical Pharmacy Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Fast-acting Human Insulin Industry Chain
8.2 Fast-acting Human Insulin Upstream Analysis
8.2.1 Fast-acting Human Insulin Core Raw Materials
8.2.2 Main Manufacturers of Fast-acting Human Insulin Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Fast-acting Human Insulin Production Mode
8.6 Fast-acting Human Insulin Procurement Model
8.7 Fast-acting Human Insulin Industry Sales Model and Sales Channels
8.7.1 Fast-acting Human Insulin Sales Model
8.7.2 Fast-acting Human Insulin Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Fast-acting Human Insulin Introduction
1.2 World Fast-acting Human Insulin Supply & Forecast
1.2.1 World Fast-acting Human Insulin Production Value (2018 & 2022 & 2029)
1.2.2 World Fast-acting Human Insulin Production (2018-2029)
1.2.3 World Fast-acting Human Insulin Pricing Trends (2018-2029)
1.3 World Fast-acting Human Insulin Production by Region (Based on Production Site)
1.3.1 World Fast-acting Human Insulin Production Value by Region (2018-2029)
1.3.2 World Fast-acting Human Insulin Production by Region (2018-2029)
1.3.3 World Fast-acting Human Insulin Average Price by Region (2018-2029)
1.3.4 North America Fast-acting Human Insulin Production (2018-2029)
1.3.5 Europe Fast-acting Human Insulin Production (2018-2029)
1.3.6 China Fast-acting Human Insulin Production (2018-2029)
1.3.7 Japan Fast-acting Human Insulin Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Fast-acting Human Insulin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Fast-acting Human Insulin Major Market Trends
2 DEMAND SUMMARY
2.1 World Fast-acting Human Insulin Demand (2018-2029)
2.2 World Fast-acting Human Insulin Consumption by Region
2.2.1 World Fast-acting Human Insulin Consumption by Region (2018-2023)
2.2.2 World Fast-acting Human Insulin Consumption Forecast by Region (2024-2029)
2.3 United States Fast-acting Human Insulin Consumption (2018-2029)
2.4 China Fast-acting Human Insulin Consumption (2018-2029)
2.5 Europe Fast-acting Human Insulin Consumption (2018-2029)
2.6 Japan Fast-acting Human Insulin Consumption (2018-2029)
2.7 South Korea Fast-acting Human Insulin Consumption (2018-2029)
2.8 ASEAN Fast-acting Human Insulin Consumption (2018-2029)
2.9 India Fast-acting Human Insulin Consumption (2018-2029)
3 WORLD FAST-ACTING HUMAN INSULIN MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Fast-acting Human Insulin Production Value by Manufacturer (2018-2023)
3.2 World Fast-acting Human Insulin Production by Manufacturer (2018-2023)
3.3 World Fast-acting Human Insulin Average Price by Manufacturer (2018-2023)
3.4 Fast-acting Human Insulin Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Fast-acting Human Insulin Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Fast-acting Human Insulin in 2022
3.5.3 Global Concentration Ratios (CR8) for Fast-acting Human Insulin in 2022
3.6 Fast-acting Human Insulin Market: Overall Company Footprint Analysis
3.6.1 Fast-acting Human Insulin Market: Region Footprint
3.6.2 Fast-acting Human Insulin Market: Company Product Type Footprint
3.6.3 Fast-acting Human Insulin Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Fast-acting Human Insulin Production Value Comparison
4.1.1 United States VS China: Fast-acting Human Insulin Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Fast-acting Human Insulin Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Fast-acting Human Insulin Production Comparison
4.2.1 United States VS China: Fast-acting Human Insulin Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Fast-acting Human Insulin Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Fast-acting Human Insulin Consumption Comparison
4.3.1 United States VS China: Fast-acting Human Insulin Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Fast-acting Human Insulin Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Fast-acting Human Insulin Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Fast-acting Human Insulin Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Fast-acting Human Insulin Production Value (2018-2023)
4.4.3 United States Based Manufacturers Fast-acting Human Insulin Production (2018-2023)
4.5 China Based Fast-acting Human Insulin Manufacturers and Market Share
4.5.1 China Based Fast-acting Human Insulin Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Fast-acting Human Insulin Production Value (2018-2023)
4.5.3 China Based Manufacturers Fast-acting Human Insulin Production (2018-2023)
4.6 Rest of World Based Fast-acting Human Insulin Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Fast-acting Human Insulin Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Fast-acting Human Insulin Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Fast-acting Human Insulin Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Fast-acting Human Insulin Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Lispro Insulin
5.2.2 Aspart Insulin
5.2.3 Glulisine Insulin
5.3 Market Segment by Type
5.3.1 World Fast-acting Human Insulin Production by Type (2018-2029)
5.3.2 World Fast-acting Human Insulin Production Value by Type (2018-2029)
5.3.3 World Fast-acting Human Insulin Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Fast-acting Human Insulin Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Type 1 Diabetes
6.2.2 Type 2 Diabetes
6.3 Market Segment by Application
6.3.1 World Fast-acting Human Insulin Production by Application (2018-2029)
6.3.2 World Fast-acting Human Insulin Production Value by Application (2018-2029)
6.3.3 World Fast-acting Human Insulin Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Fast-acting Human Insulin Product and Services
7.1.4 Sanofi Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
7.2 Geropharm
7.2.1 Geropharm Details
7.2.2 Geropharm Major Business
7.2.3 Geropharm Fast-acting Human Insulin Product and Services
7.2.4 Geropharm Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Geropharm Recent Developments/Updates
7.2.6 Geropharm Competitive Strengths & Weaknesses
7.3 Wockhardt
7.3.1 Wockhardt Details
7.3.2 Wockhardt Major Business
7.3.3 Wockhardt Fast-acting Human Insulin Product and Services
7.3.4 Wockhardt Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Wockhardt Recent Developments/Updates
7.3.6 Wockhardt Competitive Strengths & Weaknesses
7.4 Novo Nordisk
7.4.1 Novo Nordisk Details
7.4.2 Novo Nordisk Major Business
7.4.3 Novo Nordisk Fast-acting Human Insulin Product and Services
7.4.4 Novo Nordisk Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Novo Nordisk Recent Developments/Updates
7.4.6 Novo Nordisk Competitive Strengths & Weaknesses
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Details
7.5.2 Eli Lilly and Company Major Business
7.5.3 Eli Lilly and Company Fast-acting Human Insulin Product and Services
7.5.4 Eli Lilly and Company Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Eli Lilly and Company Recent Developments/Updates
7.5.6 Eli Lilly and Company Competitive Strengths & Weaknesses
7.6 Mannkind
7.6.1 Mannkind Details
7.6.2 Mannkind Major Business
7.6.3 Mannkind Fast-acting Human Insulin Product and Services
7.6.4 Mannkind Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Mannkind Recent Developments/Updates
7.6.6 Mannkind Competitive Strengths & Weaknesses
7.7 Biocon
7.7.1 Biocon Details
7.7.2 Biocon Major Business
7.7.3 Biocon Fast-acting Human Insulin Product and Services
7.7.4 Biocon Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Biocon Recent Developments/Updates
7.7.6 Biocon Competitive Strengths & Weaknesses
7.8 Julphar
7.8.1 Julphar Details
7.8.2 Julphar Major Business
7.8.3 Julphar Fast-acting Human Insulin Product and Services
7.8.4 Julphar Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Julphar Recent Developments/Updates
7.8.6 Julphar Competitive Strengths & Weaknesses
7.9 ADOCIA
7.9.1 ADOCIA Details
7.9.2 ADOCIA Major Business
7.9.3 ADOCIA Fast-acting Human Insulin Product and Services
7.9.4 ADOCIA Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 ADOCIA Recent Developments/Updates
7.9.6 ADOCIA Competitive Strengths & Weaknesses
7.10 Tonghua Dongbao Pharmaceutical
7.10.1 Tonghua Dongbao Pharmaceutical Details
7.10.2 Tonghua Dongbao Pharmaceutical Major Business
7.10.3 Tonghua Dongbao Pharmaceutical Fast-acting Human Insulin Product and Services
7.10.4 Tonghua Dongbao Pharmaceutical Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
7.10.6 Tonghua Dongbao Pharmaceutical Competitive Strengths & Weaknesses
7.11 Gan & Lee Pharmaceuticals
7.11.1 Gan & Lee Pharmaceuticals Details
7.11.2 Gan & Lee Pharmaceuticals Major Business
7.11.3 Gan & Lee Pharmaceuticals Fast-acting Human Insulin Product and Services
7.11.4 Gan & Lee Pharmaceuticals Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Gan & Lee Pharmaceuticals Recent Developments/Updates
7.11.6 Gan & Lee Pharmaceuticals Competitive Strengths & Weaknesses
7.12 Zhejiang Hisun Pharmaceutical
7.12.1 Zhejiang Hisun Pharmaceutical Details
7.12.2 Zhejiang Hisun Pharmaceutical Major Business
7.12.3 Zhejiang Hisun Pharmaceutical Fast-acting Human Insulin Product and Services
7.12.4 Zhejiang Hisun Pharmaceutical Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
7.12.6 Zhejiang Hisun Pharmaceutical Competitive Strengths & Weaknesses
7.13 Wuhan Biology Chemical Pharmacy
7.13.1 Wuhan Biology Chemical Pharmacy Details
7.13.2 Wuhan Biology Chemical Pharmacy Major Business
7.13.3 Wuhan Biology Chemical Pharmacy Fast-acting Human Insulin Product and Services
7.13.4 Wuhan Biology Chemical Pharmacy Fast-acting Human Insulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Wuhan Biology Chemical Pharmacy Recent Developments/Updates
7.13.6 Wuhan Biology Chemical Pharmacy Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Fast-acting Human Insulin Industry Chain
8.2 Fast-acting Human Insulin Upstream Analysis
8.2.1 Fast-acting Human Insulin Core Raw Materials
8.2.2 Main Manufacturers of Fast-acting Human Insulin Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Fast-acting Human Insulin Production Mode
8.6 Fast-acting Human Insulin Procurement Model
8.7 Fast-acting Human Insulin Industry Sales Model and Sales Channels
8.7.1 Fast-acting Human Insulin Sales Model
8.7.2 Fast-acting Human Insulin Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Fast-acting Human Insulin Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Fast-acting Human Insulin Production Value by Region (2018-2023) & (USD Million)
Table 3. World Fast-acting Human Insulin Production Value by Region (2024-2029) & (USD Million)
Table 4. World Fast-acting Human Insulin Production Value Market Share by Region (2018-2023)
Table 5. World Fast-acting Human Insulin Production Value Market Share by Region (2024-2029)
Table 6. World Fast-acting Human Insulin Production by Region (2018-2023) & (K Units)
Table 7. World Fast-acting Human Insulin Production by Region (2024-2029) & (K Units)
Table 8. World Fast-acting Human Insulin Production Market Share by Region (2018-2023)
Table 9. World Fast-acting Human Insulin Production Market Share by Region (2024-2029)
Table 10. World Fast-acting Human Insulin Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Fast-acting Human Insulin Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Fast-acting Human Insulin Major Market Trends
Table 13. World Fast-acting Human Insulin Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Fast-acting Human Insulin Consumption by Region (2018-2023) & (K Units)
Table 15. World Fast-acting Human Insulin Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Fast-acting Human Insulin Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Fast-acting Human Insulin Producers in 2022
Table 18. World Fast-acting Human Insulin Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Fast-acting Human Insulin Producers in 2022
Table 20. World Fast-acting Human Insulin Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Fast-acting Human Insulin Company Evaluation Quadrant
Table 22. World Fast-acting Human Insulin Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Fast-acting Human Insulin Production Site of Key Manufacturer
Table 24. Fast-acting Human Insulin Market: Company Product Type Footprint
Table 25. Fast-acting Human Insulin Market: Company Product Application Footprint
Table 26. Fast-acting Human Insulin Competitive Factors
Table 27. Fast-acting Human Insulin New Entrant and Capacity Expansion Plans
Table 28. Fast-acting Human Insulin Mergers & Acquisitions Activity
Table 29. United States VS China Fast-acting Human Insulin Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Fast-acting Human Insulin Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Fast-acting Human Insulin Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Fast-acting Human Insulin Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Fast-acting Human Insulin Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Fast-acting Human Insulin Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Fast-acting Human Insulin Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Fast-acting Human Insulin Production Market Share (2018-2023)
Table 37. China Based Fast-acting Human Insulin Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Fast-acting Human Insulin Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Fast-acting Human Insulin Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Fast-acting Human Insulin Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Fast-acting Human Insulin Production Market Share (2018-2023)
Table 42. Rest of World Based Fast-acting Human Insulin Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Fast-acting Human Insulin Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Fast-acting Human Insulin Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Fast-acting Human Insulin Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Fast-acting Human Insulin Production Market Share (2018-2023)
Table 47. World Fast-acting Human Insulin Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Fast-acting Human Insulin Production by Type (2018-2023) & (K Units)
Table 49. World Fast-acting Human Insulin Production by Type (2024-2029) & (K Units)
Table 50. World Fast-acting Human Insulin Production Value by Type (2018-2023) & (USD Million)
Table 51. World Fast-acting Human Insulin Production Value by Type (2024-2029) & (USD Million)
Table 52. World Fast-acting Human Insulin Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Fast-acting Human Insulin Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Fast-acting Human Insulin Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Fast-acting Human Insulin Production by Application (2018-2023) & (K Units)
Table 56. World Fast-acting Human Insulin Production by Application (2024-2029) & (K Units)
Table 57. World Fast-acting Human Insulin Production Value by Application (2018-2023) & (USD Million)
Table 58. World Fast-acting Human Insulin Production Value by Application (2024-2029) & (USD Million)
Table 59. World Fast-acting Human Insulin Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Fast-acting Human Insulin Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Major Business
Table 63. Sanofi Fast-acting Human Insulin Product and Services
Table 64. Sanofi Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Sanofi Recent Developments/Updates
Table 66. Sanofi Competitive Strengths & Weaknesses
Table 67. Geropharm Basic Information, Manufacturing Base and Competitors
Table 68. Geropharm Major Business
Table 69. Geropharm Fast-acting Human Insulin Product and Services
Table 70. Geropharm Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Geropharm Recent Developments/Updates
Table 72. Geropharm Competitive Strengths & Weaknesses
Table 73. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 74. Wockhardt Major Business
Table 75. Wockhardt Fast-acting Human Insulin Product and Services
Table 76. Wockhardt Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Wockhardt Recent Developments/Updates
Table 78. Wockhardt Competitive Strengths & Weaknesses
Table 79. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 80. Novo Nordisk Major Business
Table 81. Novo Nordisk Fast-acting Human Insulin Product and Services
Table 82. Novo Nordisk Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Novo Nordisk Recent Developments/Updates
Table 84. Novo Nordisk Competitive Strengths & Weaknesses
Table 85. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 86. Eli Lilly and Company Major Business
Table 87. Eli Lilly and Company Fast-acting Human Insulin Product and Services
Table 88. Eli Lilly and Company Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Eli Lilly and Company Recent Developments/Updates
Table 90. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 91. Mannkind Basic Information, Manufacturing Base and Competitors
Table 92. Mannkind Major Business
Table 93. Mannkind Fast-acting Human Insulin Product and Services
Table 94. Mannkind Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Mannkind Recent Developments/Updates
Table 96. Mannkind Competitive Strengths & Weaknesses
Table 97. Biocon Basic Information, Manufacturing Base and Competitors
Table 98. Biocon Major Business
Table 99. Biocon Fast-acting Human Insulin Product and Services
Table 100. Biocon Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Biocon Recent Developments/Updates
Table 102. Biocon Competitive Strengths & Weaknesses
Table 103. Julphar Basic Information, Manufacturing Base and Competitors
Table 104. Julphar Major Business
Table 105. Julphar Fast-acting Human Insulin Product and Services
Table 106. Julphar Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Julphar Recent Developments/Updates
Table 108. Julphar Competitive Strengths & Weaknesses
Table 109. ADOCIA Basic Information, Manufacturing Base and Competitors
Table 110. ADOCIA Major Business
Table 111. ADOCIA Fast-acting Human Insulin Product and Services
Table 112. ADOCIA Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. ADOCIA Recent Developments/Updates
Table 114. ADOCIA Competitive Strengths & Weaknesses
Table 115. Tonghua Dongbao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Tonghua Dongbao Pharmaceutical Major Business
Table 117. Tonghua Dongbao Pharmaceutical Fast-acting Human Insulin Product and Services
Table 118. Tonghua Dongbao Pharmaceutical Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Tonghua Dongbao Pharmaceutical Recent Developments/Updates
Table 120. Tonghua Dongbao Pharmaceutical Competitive Strengths & Weaknesses
Table 121. Gan & Lee Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 122. Gan & Lee Pharmaceuticals Major Business
Table 123. Gan & Lee Pharmaceuticals Fast-acting Human Insulin Product and Services
Table 124. Gan & Lee Pharmaceuticals Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Gan & Lee Pharmaceuticals Recent Developments/Updates
Table 126. Gan & Lee Pharmaceuticals Competitive Strengths & Weaknesses
Table 127. Zhejiang Hisun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 128. Zhejiang Hisun Pharmaceutical Major Business
Table 129. Zhejiang Hisun Pharmaceutical Fast-acting Human Insulin Product and Services
Table 130. Zhejiang Hisun Pharmaceutical Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
Table 132. Wuhan Biology Chemical Pharmacy Basic Information, Manufacturing Base and Competitors
Table 133. Wuhan Biology Chemical Pharmacy Major Business
Table 134. Wuhan Biology Chemical Pharmacy Fast-acting Human Insulin Product and Services
Table 135. Wuhan Biology Chemical Pharmacy Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 136. Global Key Players of Fast-acting Human Insulin Upstream (Raw Materials)
Table 137. Fast-acting Human Insulin Typical Customers
Table 138. Fast-acting Human Insulin Typical Distributors
LIST OF FIGURE
Figure 1. Fast-acting Human Insulin Picture
Figure 2. World Fast-acting Human Insulin Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Fast-acting Human Insulin Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Fast-acting Human Insulin Production (2018-2029) & (K Units)
Figure 5. World Fast-acting Human Insulin Average Price (2018-2029) & (US$/Unit)
Figure 6. World Fast-acting Human Insulin Production Value Market Share by Region (2018-2029)
Figure 7. World Fast-acting Human Insulin Production Market Share by Region (2018-2029)
Figure 8. North America Fast-acting Human Insulin Production (2018-2029) & (K Units)
Figure 9. Europe Fast-acting Human Insulin Production (2018-2029) & (K Units)
Figure 10. China Fast-acting Human Insulin Production (2018-2029) & (K Units)
Figure 11. Japan Fast-acting Human Insulin Production (2018-2029) & (K Units)
Figure 12. Fast-acting Human Insulin Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Fast-acting Human Insulin Consumption (2018-2029) & (K Units)
Figure 15. World Fast-acting Human Insulin Consumption Market Share by Region (2018-2029)
Figure 16. United States Fast-acting Human Insulin Consumption (2018-2029) & (K Units)
Figure 17. China Fast-acting Human Insulin Consumption (2018-2029) & (K Units)
Figure 18. Europe Fast-acting Human Insulin Consumption (2018-2029) & (K Units)
Figure 19. Japan Fast-acting Human Insulin Consumption (2018-2029) & (K Units)
Figure 20. South Korea Fast-acting Human Insulin Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Fast-acting Human Insulin Consumption (2018-2029) & (K Units)
Figure 22. India Fast-acting Human Insulin Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Fast-acting Human Insulin by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Fast-acting Human Insulin Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Fast-acting Human Insulin Markets in 2022
Figure 26. United States VS China: Fast-acting Human Insulin Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Fast-acting Human Insulin Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Fast-acting Human Insulin Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Fast-acting Human Insulin Production Market Share 2022
Figure 30. China Based Manufacturers Fast-acting Human Insulin Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Fast-acting Human Insulin Production Market Share 2022
Figure 32. World Fast-acting Human Insulin Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Fast-acting Human Insulin Production Value Market Share by Type in 2022
Figure 34. Lispro Insulin
Figure 35. Aspart Insulin
Figure 36. Glulisine Insulin
Figure 37. World Fast-acting Human Insulin Production Market Share by Type (2018-2029)
Figure 38. World Fast-acting Human Insulin Production Value Market Share by Type (2018-2029)
Figure 39. World Fast-acting Human Insulin Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Fast-acting Human Insulin Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Fast-acting Human Insulin Production Value Market Share by Application in 2022
Figure 42. Type 1 Diabetes
Figure 43. Type 2 Diabetes
Figure 44. World Fast-acting Human Insulin Production Market Share by Application (2018-2029)
Figure 45. World Fast-acting Human Insulin Production Value Market Share by Application (2018-2029)
Figure 46. World Fast-acting Human Insulin Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Fast-acting Human Insulin Industry Chain
Figure 48. Fast-acting Human Insulin Procurement Model
Figure 49. Fast-acting Human Insulin Sales Model
Figure 50. Fast-acting Human Insulin Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Table 1. World Fast-acting Human Insulin Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Fast-acting Human Insulin Production Value by Region (2018-2023) & (USD Million)
Table 3. World Fast-acting Human Insulin Production Value by Region (2024-2029) & (USD Million)
Table 4. World Fast-acting Human Insulin Production Value Market Share by Region (2018-2023)
Table 5. World Fast-acting Human Insulin Production Value Market Share by Region (2024-2029)
Table 6. World Fast-acting Human Insulin Production by Region (2018-2023) & (K Units)
Table 7. World Fast-acting Human Insulin Production by Region (2024-2029) & (K Units)
Table 8. World Fast-acting Human Insulin Production Market Share by Region (2018-2023)
Table 9. World Fast-acting Human Insulin Production Market Share by Region (2024-2029)
Table 10. World Fast-acting Human Insulin Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Fast-acting Human Insulin Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Fast-acting Human Insulin Major Market Trends
Table 13. World Fast-acting Human Insulin Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Fast-acting Human Insulin Consumption by Region (2018-2023) & (K Units)
Table 15. World Fast-acting Human Insulin Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Fast-acting Human Insulin Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Fast-acting Human Insulin Producers in 2022
Table 18. World Fast-acting Human Insulin Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Fast-acting Human Insulin Producers in 2022
Table 20. World Fast-acting Human Insulin Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Fast-acting Human Insulin Company Evaluation Quadrant
Table 22. World Fast-acting Human Insulin Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Fast-acting Human Insulin Production Site of Key Manufacturer
Table 24. Fast-acting Human Insulin Market: Company Product Type Footprint
Table 25. Fast-acting Human Insulin Market: Company Product Application Footprint
Table 26. Fast-acting Human Insulin Competitive Factors
Table 27. Fast-acting Human Insulin New Entrant and Capacity Expansion Plans
Table 28. Fast-acting Human Insulin Mergers & Acquisitions Activity
Table 29. United States VS China Fast-acting Human Insulin Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Fast-acting Human Insulin Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Fast-acting Human Insulin Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Fast-acting Human Insulin Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Fast-acting Human Insulin Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Fast-acting Human Insulin Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Fast-acting Human Insulin Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Fast-acting Human Insulin Production Market Share (2018-2023)
Table 37. China Based Fast-acting Human Insulin Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Fast-acting Human Insulin Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Fast-acting Human Insulin Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Fast-acting Human Insulin Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Fast-acting Human Insulin Production Market Share (2018-2023)
Table 42. Rest of World Based Fast-acting Human Insulin Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Fast-acting Human Insulin Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Fast-acting Human Insulin Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Fast-acting Human Insulin Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Fast-acting Human Insulin Production Market Share (2018-2023)
Table 47. World Fast-acting Human Insulin Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Fast-acting Human Insulin Production by Type (2018-2023) & (K Units)
Table 49. World Fast-acting Human Insulin Production by Type (2024-2029) & (K Units)
Table 50. World Fast-acting Human Insulin Production Value by Type (2018-2023) & (USD Million)
Table 51. World Fast-acting Human Insulin Production Value by Type (2024-2029) & (USD Million)
Table 52. World Fast-acting Human Insulin Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Fast-acting Human Insulin Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Fast-acting Human Insulin Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Fast-acting Human Insulin Production by Application (2018-2023) & (K Units)
Table 56. World Fast-acting Human Insulin Production by Application (2024-2029) & (K Units)
Table 57. World Fast-acting Human Insulin Production Value by Application (2018-2023) & (USD Million)
Table 58. World Fast-acting Human Insulin Production Value by Application (2024-2029) & (USD Million)
Table 59. World Fast-acting Human Insulin Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Fast-acting Human Insulin Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Major Business
Table 63. Sanofi Fast-acting Human Insulin Product and Services
Table 64. Sanofi Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Sanofi Recent Developments/Updates
Table 66. Sanofi Competitive Strengths & Weaknesses
Table 67. Geropharm Basic Information, Manufacturing Base and Competitors
Table 68. Geropharm Major Business
Table 69. Geropharm Fast-acting Human Insulin Product and Services
Table 70. Geropharm Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Geropharm Recent Developments/Updates
Table 72. Geropharm Competitive Strengths & Weaknesses
Table 73. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 74. Wockhardt Major Business
Table 75. Wockhardt Fast-acting Human Insulin Product and Services
Table 76. Wockhardt Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Wockhardt Recent Developments/Updates
Table 78. Wockhardt Competitive Strengths & Weaknesses
Table 79. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 80. Novo Nordisk Major Business
Table 81. Novo Nordisk Fast-acting Human Insulin Product and Services
Table 82. Novo Nordisk Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Novo Nordisk Recent Developments/Updates
Table 84. Novo Nordisk Competitive Strengths & Weaknesses
Table 85. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 86. Eli Lilly and Company Major Business
Table 87. Eli Lilly and Company Fast-acting Human Insulin Product and Services
Table 88. Eli Lilly and Company Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Eli Lilly and Company Recent Developments/Updates
Table 90. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 91. Mannkind Basic Information, Manufacturing Base and Competitors
Table 92. Mannkind Major Business
Table 93. Mannkind Fast-acting Human Insulin Product and Services
Table 94. Mannkind Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Mannkind Recent Developments/Updates
Table 96. Mannkind Competitive Strengths & Weaknesses
Table 97. Biocon Basic Information, Manufacturing Base and Competitors
Table 98. Biocon Major Business
Table 99. Biocon Fast-acting Human Insulin Product and Services
Table 100. Biocon Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Biocon Recent Developments/Updates
Table 102. Biocon Competitive Strengths & Weaknesses
Table 103. Julphar Basic Information, Manufacturing Base and Competitors
Table 104. Julphar Major Business
Table 105. Julphar Fast-acting Human Insulin Product and Services
Table 106. Julphar Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Julphar Recent Developments/Updates
Table 108. Julphar Competitive Strengths & Weaknesses
Table 109. ADOCIA Basic Information, Manufacturing Base and Competitors
Table 110. ADOCIA Major Business
Table 111. ADOCIA Fast-acting Human Insulin Product and Services
Table 112. ADOCIA Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. ADOCIA Recent Developments/Updates
Table 114. ADOCIA Competitive Strengths & Weaknesses
Table 115. Tonghua Dongbao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Tonghua Dongbao Pharmaceutical Major Business
Table 117. Tonghua Dongbao Pharmaceutical Fast-acting Human Insulin Product and Services
Table 118. Tonghua Dongbao Pharmaceutical Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Tonghua Dongbao Pharmaceutical Recent Developments/Updates
Table 120. Tonghua Dongbao Pharmaceutical Competitive Strengths & Weaknesses
Table 121. Gan & Lee Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 122. Gan & Lee Pharmaceuticals Major Business
Table 123. Gan & Lee Pharmaceuticals Fast-acting Human Insulin Product and Services
Table 124. Gan & Lee Pharmaceuticals Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Gan & Lee Pharmaceuticals Recent Developments/Updates
Table 126. Gan & Lee Pharmaceuticals Competitive Strengths & Weaknesses
Table 127. Zhejiang Hisun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 128. Zhejiang Hisun Pharmaceutical Major Business
Table 129. Zhejiang Hisun Pharmaceutical Fast-acting Human Insulin Product and Services
Table 130. Zhejiang Hisun Pharmaceutical Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
Table 132. Wuhan Biology Chemical Pharmacy Basic Information, Manufacturing Base and Competitors
Table 133. Wuhan Biology Chemical Pharmacy Major Business
Table 134. Wuhan Biology Chemical Pharmacy Fast-acting Human Insulin Product and Services
Table 135. Wuhan Biology Chemical Pharmacy Fast-acting Human Insulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 136. Global Key Players of Fast-acting Human Insulin Upstream (Raw Materials)
Table 137. Fast-acting Human Insulin Typical Customers
Table 138. Fast-acting Human Insulin Typical Distributors
LIST OF FIGURE
Figure 1. Fast-acting Human Insulin Picture
Figure 2. World Fast-acting Human Insulin Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Fast-acting Human Insulin Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Fast-acting Human Insulin Production (2018-2029) & (K Units)
Figure 5. World Fast-acting Human Insulin Average Price (2018-2029) & (US$/Unit)
Figure 6. World Fast-acting Human Insulin Production Value Market Share by Region (2018-2029)
Figure 7. World Fast-acting Human Insulin Production Market Share by Region (2018-2029)
Figure 8. North America Fast-acting Human Insulin Production (2018-2029) & (K Units)
Figure 9. Europe Fast-acting Human Insulin Production (2018-2029) & (K Units)
Figure 10. China Fast-acting Human Insulin Production (2018-2029) & (K Units)
Figure 11. Japan Fast-acting Human Insulin Production (2018-2029) & (K Units)
Figure 12. Fast-acting Human Insulin Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Fast-acting Human Insulin Consumption (2018-2029) & (K Units)
Figure 15. World Fast-acting Human Insulin Consumption Market Share by Region (2018-2029)
Figure 16. United States Fast-acting Human Insulin Consumption (2018-2029) & (K Units)
Figure 17. China Fast-acting Human Insulin Consumption (2018-2029) & (K Units)
Figure 18. Europe Fast-acting Human Insulin Consumption (2018-2029) & (K Units)
Figure 19. Japan Fast-acting Human Insulin Consumption (2018-2029) & (K Units)
Figure 20. South Korea Fast-acting Human Insulin Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Fast-acting Human Insulin Consumption (2018-2029) & (K Units)
Figure 22. India Fast-acting Human Insulin Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Fast-acting Human Insulin by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Fast-acting Human Insulin Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Fast-acting Human Insulin Markets in 2022
Figure 26. United States VS China: Fast-acting Human Insulin Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Fast-acting Human Insulin Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Fast-acting Human Insulin Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Fast-acting Human Insulin Production Market Share 2022
Figure 30. China Based Manufacturers Fast-acting Human Insulin Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Fast-acting Human Insulin Production Market Share 2022
Figure 32. World Fast-acting Human Insulin Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Fast-acting Human Insulin Production Value Market Share by Type in 2022
Figure 34. Lispro Insulin
Figure 35. Aspart Insulin
Figure 36. Glulisine Insulin
Figure 37. World Fast-acting Human Insulin Production Market Share by Type (2018-2029)
Figure 38. World Fast-acting Human Insulin Production Value Market Share by Type (2018-2029)
Figure 39. World Fast-acting Human Insulin Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Fast-acting Human Insulin Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Fast-acting Human Insulin Production Value Market Share by Application in 2022
Figure 42. Type 1 Diabetes
Figure 43. Type 2 Diabetes
Figure 44. World Fast-acting Human Insulin Production Market Share by Application (2018-2029)
Figure 45. World Fast-acting Human Insulin Production Value Market Share by Application (2018-2029)
Figure 46. World Fast-acting Human Insulin Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Fast-acting Human Insulin Industry Chain
Figure 48. Fast-acting Human Insulin Procurement Model
Figure 49. Fast-acting Human Insulin Sales Model
Figure 50. Fast-acting Human Insulin Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
